Is intraoperative parathyroid hormone testing in patients with renal insufficiency undergoing parathyroidectomy for primary hyperparathyroidism accurate?

Our aim was to determine whether chronic renal insufficiency (CRI) impacted intraoperative parathyroid hormone (ioPTH) monitoring during parathyroidectomy. We hypothesized that ioPTH monitoring in patients with CRI would show slower decline, but would still accurately predict cure.
A retrospective review was conducted of patients with primary hyperparathyroidism who underwent curative single adenoma parathyroidectomy. The percentage of patients reaching 50% decline of ioPTH was compared between groups stratified by renal function.
Between 2000 and 2013, 950 patients met inclusion criteria. At 5 minutes, 66% of patients with CRI met curative criteria versus 77% of normal renal function patients (P = .001). At 10 minutes, 89% vs 92% met criteria (P = .073), and by 15 minutes, the gap narrowed to 95% vs 97% (P = .142), respectively.
Despite CRI patients with primary hyperparathyroidism having slower ioPTH decline after curative parathyroidectomy, 95% met ioPTH criteria by 15 minutes. Standard ioPTH criteria can be used with CRI patients.
AuthorsJonathan A Sohn, Sarah C Oltmann, David F Schneider, Rebecca S Sippel, Herbert Chen, Dawn M Elfenbein
JournalAmerican journal of surgery (Am J Surg) Vol. 209 Issue 3 Pg. 483-7 (Mar 2015) ISSN: 1879-1883 [Electronic] United States
PMID25556028 (Publication Type: Journal Article)
CopyrightCopyright © 2015 Elsevier Inc. All rights reserved.
Chemical References
  • Parathyroid Hormone
  • Creatinine
  • Aged
  • Creatinine (blood)
  • Female
  • Follow-Up Studies
  • Humans
  • Hyperparathyroidism, Primary (blood, complications, surgery)
  • Male
  • Middle Aged
  • Minimally Invasive Surgical Procedures
  • Monitoring, Intraoperative (methods)
  • Parathyroid Hormone (blood)
  • Parathyroidectomy (methods)
  • Renal Insufficiency (blood, complications)
  • Reproducibility of Results
  • Retrospective Studies
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: